1364 Recruiting Trials

Clinical Trials for Obesity

Obesity trials study GLP-1 receptor agonists, bariatric procedures, behavioural interventions, and combination weight-loss therapies in adults and adolescents.

Showing 15 of 1364 recruiting trials

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
PHASE2 Chandler, Arizona +4 more NCT06143956
Recruiting
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
NA Columbia, Missouri +4 more NCT06335771
Recruiting
Motivating Increases in Physical Activity for Prevention of Weight Regain After Metabolic Bariatric Surgery
NA Hartford, Connecticut +4 more NCT06484621
Recruiting
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)
N/A Columbia, Missouri +4 more NCT06571474
Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
PHASE3 Dothan, Alabama +4 more NCT06937086
Recruiting
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
PHASE3 Dothan, Alabama +4 more NCT06937099
Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
PHASE3 Phoenix, Arizona +4 more NCT07153471
Recruiting
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
PHASE3 Birmingham, Alabama +4 more NCT07202884
Recruiting
A Sensory Strategy to Cut Sugary Beverages in African/American and Latine Adolescents
NA Bloomington, Indiana +4 more NCT07223151
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
PHASE3 Birmingham, Alabama +4 more NCT07282600
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
PHASE3 Tuscaloosa, Alabama +4 more NCT07321886
Recruiting
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
PHASE3 Mobile, Alabama +4 more NCT07353931
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
PHASE3 Cullman, Alabama +4 more NCT07369011
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
PHASE3 Birmingham, Alabama +4 more NCT07392190
Recruiting
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
PHASE2 Chandler, Arizona +4 more NCT07589608
Recruiting
See all 1364 results

Check Your Eligibility

Create a free profile and our AI will match you to trials you may qualify for.

Get Matched — Free
No insurance required
Browse by Condition
Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19
Browse by State
California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon